**Question:** Fluoroacetate inhibits

A. Pyruvate Dehydrogenase Complex (PDC)
B. Citrate Synthase
C. α-Ketoglutarate Dehydrogenase Complex (KGDH)
D. Fatty Acid Oxidation

**Core Concept:** Fluoroacetate is a known inhibitor of the pyruvate dehydrogenase complex (PDC) in the cellular respiration pathway. The pyruvate dehydrogenase complex is an essential enzyme that plays a crucial role in the process of cellular respiration, converting pyruvate into acetyl-CoA for entry into the Krebs cycle.

**Why the Correct Answer is Right:** Fluoroacetate directly binds to and inhibits the E1 subunit of the pyruvate dehydrogenase complex, preventing the conversion of pyruvate to acetyl-CoA. This inhibition leads to a decrease in overall cellular respiration and ATP production, ultimately causing the disruption of energy homeostasis in the cells.

**Why Each Wrong Option is Incorrect:**

A. Pyruvate Dehydrogenase Complex (PDC) is the correct target of fluoroacetate, as explained above.
B. Citrate Synthase is an enzyme involved in the Citric Acid Cycle (Krebs Cycle) and is not inhibited by fluoroacetate.
C. α-Ketoglutarate Dehydrogenase Complex (KGDH) is another enzyme in the Krebs cycle and is not inhibited by fluoroacetate.
D. Fatty Acid Oxidation is a separate pathway, unrelated to fluoroacetate inhibition, as it occurs in the mitochondria, while fluoroacetate affects the PDC in the cytosol.

**Clinical Pearl:** Fluoroacetate toxicity can lead to a rare but severe condition known as Acute Fluroacetate Encephalopathy (AFE). This condition is characterized by confusion, seizures, and ultimately coma, due to the disruption of energy production in the brain, which relies heavily on cellular respiration.

**Correct Answer:** C. α-Ketoglutarate Dehydrogenase Complex (KGDH)

Fluoroacetate primarily targets the pyruvate dehydrogenase complex (PDC) and its inhibition, not the α-Ketoglutarate Dehydrogenase Complex (KGDH). Therefore, option C is incorrect. However, it is important to note that fluoroacetate toxicity can lead to a condition called Acute Fluroacetate Encephalopathy (AFE), which involves the disruption of energy production in the brain due to the inhibition of PDC.

In summary, fluoroacetate primarily inhibits the PDC, which is essential for cellular respiration in the brain and other tissues. Consequently, it is crucial for medical students and practitioners to understand the importance of this pathway and the potential consequences of its disruption, such as AFE.